KV To Settle Claims Against Citigroup In ARS MDL
KV Pharmaceutical Co. plans to resolve its case alleging that Citigroup Global Markets Inc. lied to the drugmaker about the safety of investing in auction rate securities and left it stuck...To view the full article, register now.
Already a subscriber? Click here to view full article